scispace - formally typeset
L

Loralie J. Langman

Researcher at Mayo Clinic

Publications -  74
Citations -  1822

Loralie J. Langman is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Therapeutic drug monitoring & Pharmacogenomics. The author has an hindex of 20, co-authored 71 publications receiving 1288 citations.

Papers
More filters
Journal ArticleDOI

Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction.

TL;DR: An abbreviated method validation of the Mitra Microsampling Device is reported including: accuracy, precision, linearity, carry-over, and stability using residual venous whole blood (VB) samples.
Journal ArticleDOI

The development and validation of a turbulent flow-liquid chromatography–tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum

TL;DR: A turbulent flow-liquid chromatography-tandem mass spectrometric (TFC-MS/MS) method for the robust, simultaneous quantification of citalopram, sertraline, bupropion and its active metabolite, hydroxyb upropion (OH-bupropion).
Journal ArticleDOI

High-throughput online solid-phase extraction tandem mass spectrometry: Is it right for your clinical laboratory?

TL;DR: The Agilent RapidFire 365 Mass Spectrometry system works well for several classes of medications including immunosuppressants, anticonvulsants and antineoplastic agents where dosage adjustments are made to maximize efficacy and minimize toxicity once results are available.
Journal ArticleDOI

Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseases

TL;DR: Monitoring MPA levels can help the dermatologist to increase the dose in patients who have poor absorption or to detect therapeutic noncompliance, and is recommended only in patients not responding to the standard 2-g/d dosage of MMF.